Alnylam Pharmaceuticals

  • Recommend
  • Tweet
  • Print
  • Email

Tracy Krughoff of BIO talks to Barry Greene, president and COO of Alnylam Pharmaceuticals (ALNY) at the Seventh Annual BIO Investor Forum in San Francisco. Alnylam has developed a deep pipeline of drug products to treat a multitude of diseases through RNAi therapeutics. Listen to the podcast

Hide Date: